Berta Ruiz‐León
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Berta Ruiz‐León has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Alicia Alonso‐Gómez
Hospital Felipe II Recoletas Valladolid Spain
1 shared publication - Alvaro Moreno-Ancillo
Allergy Section Hospital General Universitario Nuestra Señora del Prado Talavera de la Reina Toledo Spain
1 shared publication - Antonio Letrán
Allergy Unit Hospital HLA Jerez Puerta del Sur Jerez de la Frontera Cádiz Spain
1 shared publication - Arantza Vega
Allergy Service Hospital Universitario de Guadalajara Guadalajara Spain
1 shared publication Beatriz Pola Bibián
Centro Médico Zaragoza Zaragoza Spain
1 shared publication- Carmelo Escudero
Allergy Department Hospital Infantil Universitario Niño Jesús Madrid Spain
1 shared publication
Latest Publications
- 19 November 2026
- Published by Wiley in Clinical & Experimental Allergy
NavigAIT.me, a Digital Intervention to Improve Long‐Term Adherence in Allergen Immunotherapy: Design of a Multicentre Randomised Trial
Summary: Evaluating the real‐life effectiveness of a new digital intervention to improve persistence in allergen immunotherapy (AIT). Assessing persistence, implementation, effectiveness and satisfaction with AIT in a randomised controlled prospective large‐scale trial.
- 19 November 2026
- Published by Wiley in Clinical & Experimental Allergy
NavigAIT.me, a Digital Intervention to Improve Long‐Term Adherence in Allergen Immunotherapy: Design of a Multicentre Randomised Trial
Summary: Evaluating the real‐life effectiveness of a new digital intervention to improve persistence in allergen immunotherapy (AIT). Assessing persistence, implementation, effectiveness and satisfaction with AIT in a randomised controlled prospective large‐scale trial.
The Sting Challenge Test: An EAACI Position Paper on Hymenoptera Venom Allergy
A Sting Challenge Test (SCT) is the only reliable method to verify the effectiveness of venom immunotherapy (VIT) in patients allergic to Hymenoptera venom, a leading cause of anaphylaxis in adults. This European Academy of Allergy and Clinical Immunology (EAACI) position paper provides an in‐depth analysis of the SCT's key applications, risks, and outcomes in clinical practice, focusing on its role in monitoring VIT efficacy, improving patient quality of life, and ensuring appropriate therapeutic interventions. The SCT is primarily used to assess VIT protection, adjust VIT dosage, and confirm patient safety but is not recommended for routine diagnosis due to the risk of provoking systemic allergic reactions. This position paper also offers practical considerations for performing the SCT, including insect handling, patient preparation, and risk management. While SCT is a valuable tool in personalized allergy treatment, it requires careful handling of live insects and patient preparation to ensure safety. This position paper reviews the literature and presents the expert experience of the Insect Venom Hypersensitivity Working Group of the European Academy of Allergy and Clinical Immunology.
The Sting Challenge Test: An EAACI Position Paper on Hymenoptera Venom Allergy
A Sting Challenge Test (SCT) is the only reliable method to verify the effectiveness of venom immunotherapy (VIT) in patients allergic to Hymenoptera venom, a leading cause of anaphylaxis in adults. This European Academy of Allergy and Clinical Immunology (EAACI) position paper provides an in‐depth analysis of the SCT's key applications, risks, and outcomes in clinical practice, focusing on its role in monitoring VIT efficacy, improving patient quality of life, and ensuring appropriate therapeutic interventions. The SCT is primarily used to assess VIT protection, adjust VIT dosage, and confirm patient safety but is not recommended for routine diagnosis due to the risk of provoking systemic allergic reactions. This position paper also offers practical considerations for performing the SCT, including insect handling, patient preparation, and risk management. While SCT is a valuable tool in personalized allergy treatment, it requires careful handling of live insects and patient preparation to ensure safety. This position paper reviews the literature and presents the expert experience of the Insect Venom Hypersensitivity Working Group of the European Academy of Allergy and Clinical Immunology.